In a 72-year-old woman with hypertension treated with losartan 100 mg once daily and amlodipine 10 mg once daily who presents with lightheadedness and weakness but has stable vital signs and an unremarkable physical examination, what initial medication(s) should be started?

Management of Lightheadedness in an Elderly Hypertensive Patient

Do not start any new medications at this time; instead, reduce or discontinue the current antihypertensive regimen, as this patient's symptoms are most likely medication-induced orthostatic hypotension or overtreatment of blood pressure.

Clinical Assessment Priority

This 72-year-old woman is already on maximum doses of two antihypertensive agents (losartan 100 mg and amlodipine 10 mg daily), yet presents with lightheadedness and weakness—classic symptoms of hypotension or orthostatic changes. The question asks what medications to "start," but the appropriate clinical action is to evaluate and likely reduce her current medications, not add new ones.

Key Diagnostic Considerations

• Measure orthostatic vital signs immediately: Blood pressure should be measured in both supine and standing positions, as elderly patients on antihypertensive therapy are at increased risk for postural hypotension 1
• Verify actual blood pressure values: With "stable vital signs" reported, determine if BP is at target, below target, or if orthostatic changes exist
• Assess medication adherence and timing: Both medications are once-daily dosing, but timing and compliance affect symptom presentation 2

Management Algorithm Based on Blood Pressure Findings

If Blood Pressure is Below Target (<130/80 mmHg)

Reduce antihypertensive burden:

• Consider decreasing amlodipine from 10 mg to 5 mg first, as calcium channel blockers can cause dizziness and are dose-dependent for side effects 3, 4
• Alternatively, reduce losartan from 100 mg to 50 mg 5
• The 2020 ISH guidelines emphasize individualizing BP targets for elderly patients based on frailty, with targets of 140/90 mmHg being acceptable 2

If Blood Pressure is at Target but Symptomatic

Reassess the appropriateness of intensive BP control:

• For patients aged 72 years, especially if frail, a less intensive BP target (140/90 mmHg rather than 130/80 mmHg) may be more appropriate 2
• The 2007 ESH/ESC guidelines note that initial doses and titration should be more gradual in elderly patients due to greater chance of adverse effects 1
• Consider that she is on maximum doses of both agents, which may be excessive for her physiologic needs

If Orthostatic Hypotension is Documented

Modify the regimen to reduce orthostatic effects:

• Amlodipine has a long half-life (35-50 hours) and provides 24-hour coverage, making it less likely to cause acute orthostatic changes but can contribute to overall BP reduction 4
• Losartan can cause dizziness upon standing, particularly at higher doses 6
• Reduce total antihypertensive burden by decreasing one or both medications

Why NOT to Start New Medications

Adding medications would be inappropriate because:

• The patient is already on dual therapy at maximum doses (losartan 100 mg + amlodipine 10 mg) 5
• Her symptoms (lightheadedness, weakness) are consistent with medication side effects, not undertreated hypertension 6, 7
• The 2020 ISH guidelines recommend considering monotherapy in patients aged >80 years or frail, suggesting this patient may already be overtreated 2
• Both amlodipine and losartan can cause dizziness as adverse effects 6, 8

Specific Medication Considerations

Amlodipine Profile in Elderly

• Effective in elderly patients with good tolerability 3
• Dose-dependent side effects including dizziness and edema, more common at 10 mg dose 4
• Long half-life provides sustained BP control but may contribute to persistent symptoms 4

Losartan Profile in Elderly

• Well-tolerated in elderly patients 9, 8
• Can cause dizziness upon standing, particularly when combined with other antihypertensives 6
• At 100 mg daily, patient is at maximum recommended dose 5

Common Pitfalls to Avoid

• Do not add a third antihypertensive agent without first reassessing the appropriateness of current therapy
• Do not assume stable vital signs mean optimal BP control—measure orthostatic changes specifically 1
• Do not overlook medication-induced symptoms in favor of adding symptomatic treatments
• Do not apply aggressive BP targets (<130/80 mmHg) to elderly or frail patients without considering tolerability 2

Recommended Immediate Actions

1. Obtain orthostatic vital signs (supine and standing BP after 1-3 minutes) 1
2. Review actual BP values to determine if patient is below, at, or above target
3. Reduce antihypertensive burden by decreasing amlodipine to 5 mg daily or losartan to 50 mg daily 5, 3
4. Reassess in 1-2 weeks after medication adjustment
5. Consider target BP of 140/90 mmHg as appropriate for this elderly patient 2, 1